Send us Feedback

Ev3 (EVVV)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EVVV » Topics » SIGNATURES

These excerpts taken from the EVVV 10-K filed Feb 27, 2009.
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
ev3 INC.
 
Dated: February 27, 2009
  By 
/s/  Robert J. Palmisano
Robert J. Palmisano
President and Chief Executive Officer (principal executive officer)
 
  By 
/s/  Shawn McCormick
Shawn McCormick
Senior Vice President and Chief Financial Officer
(principal financial and accounting officer)
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
             
Name and Signature
 
Title
 
Date
 
         
/s/  Robert J. Palmisano

Robert J. Palmisano 		  President and
Chief Executive Officer 		  February 27, 2009
         
/s/  Daniel J. Levangie

Daniel J. Levangie 		  Chairman of the Board   February 27, 2009
         
/s/  John K. Bakewell

John K. Bakewell 		  Director   February 27, 2009
         
/s/  Jeffrey B. Child

Jeffrey B. Child 		  Director   February 27, 2009
         
/s/  Richard B. Emmitt

Richard B. Emmitt 		  Director   February 27, 2009
         
/s/  Douglas W. Kohrs

Douglas W. Kohrs 		  Director   February 27, 2009
         
/s/  John L. Miclot

John L. Miclot 		  Director   February 27, 2009
         
/s/  Thomas E. Timbie

Thomas E. Timbie 		  Director   February 27, 2009
         
/s/  Elizabeth H. Weatherman

Elizabeth H. Weatherman 		  Director   February 27, 2009


95

Table of Contents

SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
ev3 INC.
 
Dated: February 27, 2009
  By 
/s/  Robert J. Palmisano
Robert J. Palmisano
President and Chief Executive Officer (principal executive officer)
 
  By 
/s/  Shawn McCormick
Shawn McCormick
Senior Vice President and Chief Financial Officer
(principal financial and accounting officer)
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
             
Name and Signature
 
Title
 
Date
 
         
/s/  Robert J. Palmisano

Robert J. Palmisano 		  President and
Chief Executive Officer 		  February 27, 2009
         
/s/  Daniel J. Levangie

Daniel J. Levangie 		  Chairman of the Board   February 27, 2009
         
/s/  John K. Bakewell

John K. Bakewell 		  Director   February 27, 2009
         
/s/  Jeffrey B. Child

Jeffrey B. Child 		  Director   February 27, 2009
         
/s/  Richard B. Emmitt

Richard B. Emmitt 		  Director   February 27, 2009
         
/s/  Douglas W. Kohrs

Douglas W. Kohrs 		  Director   February 27, 2009
         
/s/  John L. Miclot

John L. Miclot 		  Director   February 27, 2009
         
/s/  Thomas E. Timbie

Thomas E. Timbie 		  Director   February 27, 2009
         
/s/  Elizabeth H. Weatherman

Elizabeth H. Weatherman 		  Director   February 27, 2009


95

Table of Contents

SIGNATURES


 



Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.


 



ev3 INC.


 



Dated: February 27, 2009
















  By 
/s/  Robert
J. Palmisano






Robert J. Palmisano



President and Chief Executive Officer (principal executive
officer)


 
















  By 
/s/  Shawn
McCormick






Shawn McCormick



Senior Vice President and Chief Financial Officer



(principal financial and accounting officer)


 


 



Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.


 






















































































































































             


Name and Signature


 


Title


 


Date

 

 

 

 

 

 

/s/  Robert
J. Palmisano


Robert
J. Palmisano

 

President and

Chief Executive Officer

 

February 27, 2009

 

 

 

 

 

/s/  Daniel
J. Levangie


Daniel
J. Levangie

 

Chairman of the Board

 

February 27, 2009

 

 

 

 

 

/s/  John
K. Bakewell


John
K. Bakewell

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Jeffrey
B. Child


Jeffrey
B. Child

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Richard
B. Emmitt


Richard
B. Emmitt

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Douglas
W. Kohrs


Douglas
W. Kohrs

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  John
L. Miclot


John
L. Miclot

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Thomas
E. Timbie


Thomas
E. Timbie

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Elizabeth
H. Weatherman


Elizabeth
H. Weatherman

 

Director

 

February 27, 2009









95




Table of Contents







SIGNATURES


 



Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.


 



ev3 INC.


 



Dated: February 27, 2009
















  By 
/s/  Robert
J. Palmisano






Robert J. Palmisano



President and Chief Executive Officer (principal executive
officer)


 
















  By 
/s/  Shawn
McCormick






Shawn McCormick



Senior Vice President and Chief Financial Officer



(principal financial and accounting officer)


 


 



Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.


 






















































































































































             


Name and Signature


 


Title


 


Date

 

 

 

 

 

 

/s/  Robert
J. Palmisano


Robert
J. Palmisano

 

President and

Chief Executive Officer

 

February 27, 2009

 

 

 

 

 

/s/  Daniel
J. Levangie


Daniel
J. Levangie

 

Chairman of the Board

 

February 27, 2009

 

 

 

 

 

/s/  John
K. Bakewell


John
K. Bakewell

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Jeffrey
B. Child


Jeffrey
B. Child

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Richard
B. Emmitt


Richard
B. Emmitt

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Douglas
W. Kohrs


Douglas
W. Kohrs

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  John
L. Miclot


John
L. Miclot

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Thomas
E. Timbie


Thomas
E. Timbie

 

Director

 

February 27, 2009

 

 

 

 

 

/s/  Elizabeth
H. Weatherman


Elizabeth
H. Weatherman

 

Director

 

February 27, 2009









95




Table of Contents







These excerpts taken from the EVVV 10-K filed Mar 13, 2008.
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
ev3 INC.
 
Dated: March 13, 2008
  By 
/s/  James M. Corbett
James M. Corbett
Chairman, President and Chief Executive Officer (principal executive officer)
 
  By 
/s/  Patrick D. Spangler
Patrick D. Spangler
Senior Vice President and Chief Financial Officer
(principal financing and accounting officer)
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
             
Name and Signature
 
Title
 
Date
 
         
/s/  James M. Corbett

James M. Corbett 		  Chairman, President and
Chief Executive Officer 		  March 13, 2008
         
/s/  John K. Bakewell

John K. Bakewell 		  Director   March 13, 2008
         
/s/  Jeffrey B. Child

Jeffrey B. Child 		  Director   March 13, 2008
         
/s/  Richard B. Emmitt

Richard B. Emmitt 		  Director   March 13, 2008
         
/s/  Richard N. Kender

Richard N. Kender 		  Director   March 13, 2008
         
/s/  Daniel J. Levangie

Daniel J. Levangie 		  Director   March 13, 2008
         
/s/  Myrtle S. Potter

Myrtle S. Potter 		  Director   March 13, 2008
         
/s/  Thomas E. Timbie

Thomas E. Timbie 		  Director   March 13, 2008
         
/s/  Elizabeth H. Weatherman

Elizabeth H. Weatherman 		  Director   March 13, 2008


94

Table of Contents

SIGNATURES


 



Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.


 



ev3 INC.


 



Dated: March 13, 2008
















  By 
/s/  James
M. Corbett






James M. Corbett



Chairman, President and Chief Executive Officer (principal
executive officer)


 
















  By 
/s/  Patrick
D. Spangler






Patrick D. Spangler



Senior Vice President and Chief Financial Officer



(principal financing and accounting officer)


 


 



Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.


 






















































































































































             


Name and Signature


 


Title


 


Date

 

 

 

 

 

 

/s/  James
M. Corbett


James
M. Corbett

 

Chairman, President and

Chief Executive Officer

 

March 13, 2008

 

 

 

 

 

/s/  John
K. Bakewell


John
K. Bakewell

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Jeffrey
B. Child


Jeffrey
B. Child

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Richard
B. Emmitt


Richard
B. Emmitt

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Richard
N. Kender


Richard
N. Kender

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Daniel
J. Levangie


Daniel
J. Levangie

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Myrtle
S. Potter


Myrtle
S. Potter

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Thomas
E. Timbie


Thomas
E. Timbie

 

Director

 

March 13, 2008

 

 

 

 

 

/s/  Elizabeth
H. Weatherman


Elizabeth
H. Weatherman

 

Director

 

March 13, 2008









94




Table of Contents







This excerpt taken from the EVVV 8-K filed Jun 21, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 21, 2007

ev3 Inc.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Kevin M. Klemz

 

 

 

Name:

 Kevin M. Klemz

 

 

Title:

 Vice President, Secretary and Chief Legal Officer

 

3



This excerpt taken from the EVVV 8-K filed May 17, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 17, 2007

ev3 Inc.

 

 

 

 

 

By:

/s/ Kevin M. Klemz

 

Name: Kevin M. Klemz

 

Title: Vice President, Secretary and Chief Legal Officer

 



This excerpt taken from the EVVV 10-Q filed May 9, 2007.
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

May 9, 2007

ev3 Inc.

 

 

 

By:

/s/ James M. Corbett

 

 

James M. Corbett
President and Chief Executive Officer
(principal executive officer)

 

 

 

 

By:

/s/ Patrick D. Spangler

 

 

Patrick D. Spangler
Chief Financial Officer and Treasurer
(principal financial and accounting officer)

 

33



ev3 Inc.
QUARTERLY REPORT ON FORM 10-Q
EXHIBIT INDEX

Exhibit No.

 

Description

 

Method of Filing

10.1

 

First Amendment to Loan and Security Agreement between Silicon Valley Bank and ev3 Endovascular, Inc., ev3 International, Inc. and Micro Therapeutics, Inc. dated March 15, 2007

 

Incorporated by reference to Exhibit 10.1 to ev3’s Current Report on Form 8-K as filed with the Securities and Exchange Commission on March 21, 2007 (File No. 000-51348)

31.1

 

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and SEC Rule 13a-14(a)

 

Filed herewith

31.2

 

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and SEC Rule 13a-14(a)

 

Filed herewith

32.1

 

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Furnished herewith

32.2

 

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Furnished herewith

 

34


EXCERPTS ON THIS PAGE:

10-K (4 sections)
Feb 27, 2009
10-K (2 sections)
Mar 13, 2008
8-K
Jun 21, 2007
8-K
May 17, 2007
10-Q
May 9, 2007

RELATED TOPICS for EVVV:

"SIGNATURES" elsewhere:

Alcon Inc. (ACL)
RADIENT PHARMACEUTICALS Corp (ADL)
Aspyra (APY)
Artes Medical (ARTE)
The Aristotle (ARTL)
America Service Group (ASGR)
Aspect Medical Systems (ASPM)
ATS Medical (ATSI)
Celldex Therapeutics, Inc. (AVAN)
Avigen (AVGN)
Advancis Pharmaceutical (AVNC)
Avalon Pharmaceuticals (AVRX)
Biomira (BIOM)
BIOCLINICA INC (BITI)
BioProgress (BPRG)
BSD Medical (BSM)
BioSphere Medical (BSMD)
Minrad International (BUF)
Cell Genesys (CEGE)
CollaGenex Pharmaceuticals (CGPI)
Candela (CLZR)
Continucare (CNU)
Caraco Pharmaceutical Laboratories (CPD)
CuraGen (CRGN)
Zalicus Inc. (CRXX)
Chemgenex Pharmaceuticals (CXSP)
Cypress Bioscience (CYPB)
Labopharm (DDSS)
Digital Angel (DOC)
Datascope (DSCP)
Diversa (DVSA)
Eclipsys (ECLP)
Etrials Worldwide (ETWC)
Eurand N.V. (EURX)
PC GROUP, INC. (GAIT)
HLTH (HLTH)
Fibrocell Science, Inc. (ILE)
Lipid Sciences (LIPD)
GALECTIN THERAPEUTICS INC (PRW)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki